DNA Mutational and Copy Number Variation Profiling of Primary Craniofacial Osteosarcomas by Next-Generation Sequencing

Neville BW et al (2016) Oral and maxillofacial pathology, vol xiii, 4th edn. Elsevier, St. Louis, p 912

Google Scholar 

Czerniak B, Dorfman HD (2016) Dorfman and Czerniak’s bone tumors, vol xiii, 2nd edn. Elsevier, Philadelphia, p 1506

Google Scholar 

Hameed M, Horvai AE, Jordan RCK (2020) Soft tissue special issue. Head Neck Pathol 14:70–82

Article  PubMed  PubMed Central  Google Scholar 

Lee RJ et al (2015) Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study. JAMA Otolaryngol Head Neck Surg 141(5):470–477

Article  PubMed  Google Scholar 

Liang L et al (2019) An individual patient data meta-analysis on the effect of chemotherapy on survival in patients with craniofacial osteosarcoma. Head Neck 41(6):2016–2023

Article  PubMed  Google Scholar 

Bousquet M et al (2016) Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations. Ann Oncol 27(4):738–744

Article  CAS  PubMed  Google Scholar 

Chen X et al (2014) Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Rep 7(1):104–112

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kovac M et al (2015) Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency. Nat Commun 6:8940

Article  CAS  PubMed  Google Scholar 

Suehara Y et al (2019) Clinical genomic sequencing of pediatric and adult osteosarcoma reveals distinct molecular subsets with potentially targetable alterations. Clin Cancer Res 25(21):6346–6356

Article  CAS  PubMed  PubMed Central  Google Scholar 

Behjati S et al (2017) Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma. Nat Commun 8:15936

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng DT et al (2015) Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J Mol Diagn 17(3):251–264

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zehir A et al (2017) Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med 23(6):703–713

Article  CAS  PubMed  PubMed Central  Google Scholar 

Board WCOTE (2020) Soft Tissue and Bone Tumours: WHO Classification of Tumours. International Agency for Research on Cancer

Korbel JO, Campbell PJ (2013) Criteria for inference of chromothripsis in cancer genomes. Cell 152(6):1226–1236

Article  CAS  PubMed  Google Scholar 

Stephens PJ et al (2011) Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144(1):27–40

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang CZ et al (2015) Chromothripsis from DNA damage in micronuclei. Nature 522(7555):179–184

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schumacher TN, Schreiber RD (2015) Neoantigens in cancer immunotherapy. Science 348(6230):69–74

Article  CAS  PubMed  Google Scholar 

Strachan T, Read AP (2019) Human molecular genetics, vol xiii, 5th edn. CRC Press, Taylor & Francis Group, Boca Raton, p 770

Google Scholar 

Cortes-Ciriano I et al (2020) Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. Nat Genet 52(3):331–341

Article  CAS  PubMed  PubMed Central  Google Scholar 

Perry JA et al (2014) Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma. Proc Natl Acad Sci U S A 111(51):E5564–E5573

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tawbi HA et al (2017) Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol 18(11):1493–1501

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruggieri P et al (1994) Malignancies in fibrous dysplasia. Cancer 73(5):1411–1424

Article  CAS  PubMed  Google Scholar 

Qu N et al (2015) Malignant transformation in monostotic fibrous dysplasia: clinical features, imaging features, outcomes in 10 patients, and review. Medicine (Baltimore) 94(3):e369

Article  PubMed  Google Scholar 

Tanner HC Jr, Dahlin DC, Childs DS Jr (1961) Sarcoma complicating fibrous dysplasia. Probable role of radiation therapy. Oral Surg Oral Med Oral Pathol 14:837–46

Article  PubMed  Google Scholar 

Shi R et al (2022) Clinicopathological and genetic study of a rare occurrence: malignant transformation of fibrous dysplasia of the jaws. Mol Genet Genomic Med 10(1):e1861

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yap FHX et al (2021) Malignant transformation of fibrous dysplasia into osteosarcoma confirmed with TP53 somatic mutation and mutational analysis of GNAS gene. Pathology 53(5):652–654

Article  CAS  PubMed  Google Scholar 

Lee SE et al (2012) The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: meta-analysis of 168 sporadic cases. Hum Pathol 43(8):1234–1242

Article  CAS  PubMed  Google Scholar 

Jour G et al (2016) GNAS mutations in fibrous dysplasia: a comparative study of standard sequencing and locked nucleic acid PCR sequencing on decalcified and nondecalcified formalin-fixed paraffin-embedded tissues. Appl Immunohistochem Mol Morphol 24(9):660–667

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lyons J et al (1990) Two G protein oncogenes in human endocrine tumors. Science 249(4969):655–659

Article  CAS  PubMed  Google Scholar 

Kuznetsov SA et al (2008) Age-dependent demise of GNAS-mutated skeletal stem cells and “normalization” of fibrous dysplasia of bone. J Bone Miner Res 23(11):1731–1740

Article  CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif